AETHON Trademark
Trademark Overview
On Thursday, May 30, 2024, a trademark application was filed for AETHON with the United States Patent and Trademark Office. The USPTO has given the AETHON trademark a serial number of 98575759. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, December 12, 2024. This trademark is owned by AETHON THERAPEUTICS, INC.. The AETHON trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antibodies for medical purposes; antibody reagents used for the therapeutic targeting of antigens in cells and tissue for medical purposes; pharmaceutical products for the treatment of cancer
Scientific research in the field of pharmaceuticals; research and development services in the field of antibodies; medical research services in the field of cancer
General Information
| Serial Number | 98575759 |
| Word Mark | AETHON |
| Filing Date | Thursday, May 30, 2024 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Thursday, December 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the word AETHON in stylized lowercase letters; an asterisk behind the initial letter "a". |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antibodies for medical purposes; antibody reagents used for the therapeutic targeting of antigens in cells and tissue for medical purposes; pharmaceutical products for the treatment of cancer |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Scientific research in the field of pharmaceuticals; research and development services in the field of antibodies; medical research services in the field of cancer |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | AETHON THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10169 |
Trademark Events
| Event Date | Event Description |
| Thursday, May 30, 2024 | NEW APPLICATION ENTERED |
| Tuesday, October 15, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, October 15, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 12, 2024 | ASSIGNED TO EXAMINER |
